Modifying risks of secondary leukemias: Is drug scheduling important?

被引：7

作者：

Karp, JE ^{[1
]}

Smith, MA ^{[1
]}

机构：

[1] NCI,CLIN TRIALS EVALUAT PROGRAM,DIV CANC TREATMENT DIAG & CTR,BETHESDA,MD 20892

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1996年 / 88卷 / 24期

关键词：

D O I：

10.1093/jnci/88.24.1787

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1787 / 1789

页数：3

共 36 条

[1] SOMATIC-CELL GENE-MUTATIONS IN HUMANS - BIOMARKERS FOR GENOTOXICITY [J].

ALBERTINI, RJ ;

NICKLAS, JA ;

ONEILL, JP .

ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 101 :193-201

[2] INVIVO MUTATIONS IN HUMAN BLOOD-CELLS - BIOMARKERS FOR MOLECULAR EPIDEMIOLOGY [J].

ALBERTINI, RJ ;

NICKLAS, JA ;

FUSCOE, JC ;

SKOPEK, TR ;

BRANDA, RF ;

ONEILL, JP .

ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 99 :135-141

[3] Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors [J].

Aplan, PD ;

Chervinsky, DS ;

Stanulla, M ;

Burhans, WC .

BLOOD, 1996, 87 (07) :2649-2658

[4] ETOPOSIDE (VP-16-213)-INDUCED GENE ALTERATIONS - POTENTIAL CONTRIBUTION TO CELL-DEATH [J].

BERGER, NA ;

CHATTERJEE, S ;

SCHMOTZER, JA ;

HELMS, SR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8740-8743

[5]

BOKEMEYER C, 1995, J CLIN ONCOL, V13, P382

[6] Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: Correlation with scaffold attachment regions and topoisomerase II consensus binding sites [J].

Broeker, PLS ;

Super, HG ;

Thirman, MJ ;

Pomykala, H ;

Yonebayashi, Y ;

Tanabe, S ;

ZeleznikLe, N ;

Rowley, JD .

BLOOD, 1996, 87 (05) :1912-1922

[7] Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cells [J].

Chen, CL ;

Fuscoe, JC ;

Liu, Q ;

Relling, MV .

BLOOD, 1996, 88 (06) :2210-2218

[8] Relationship between cytoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide [J].

Chen, CL ;

Fuscoe, JC ;

Liu, Q ;

Pui, CH ;

Mahmoud, HH ;

Relling, MV .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (24) :1840-1847

[9]

CIMINO G, 1991, CANCER RES, V51, P6712

[10] A RANDOMIZED TRIAL OF 2 ETOPOSIDE SCHEDULES IN SMALL-CELL LUNG-CANCER - THE INFLUENCE OF PHARMACOKINETICS ON EFFICACY AND TOXICITY [J].

CLARK, PI ;

SLEVIN, ML ;

JOEL, SP ;

OSBORNE, RJ ;

TALBOT, DI ;

JOHNSON, PWM ;

REZNEK, R ;

MASUD, T ;

GREGORY, W ;

WRIGLEY, PFM .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (07) :1427-1435

← 1 2 3 4 →